Figures & data
Figure 1. Microscopic images of prepared (a) PA (SEM), (b and b1) rGO (SEM) and (c, c1 and c2) HAp loaded nano-GO/PA (SEM) samples.
![Figure 1. Microscopic images of prepared (a) PA (SEM), (b and b1) rGO (SEM) and (c, c1 and c2) HAp loaded nano-GO/PA (SEM) samples.](/cms/asset/1f394a92-ce99-4a97-af6c-00d16ec59865/ianb_a_1637883_f0001_c.jpg)
Figure 2. Spectroscopic analysis of prepared nanocomposited materials through different analytical methods (a) XRD, (b) Raman spectra and (c) FTIR spectral analysis.
![Figure 2. Spectroscopic analysis of prepared nanocomposited materials through different analytical methods (a) XRD, (b) Raman spectra and (c) FTIR spectral analysis.](/cms/asset/4d55e3cc-9e61-4073-a4c3-d9742f1cd6ed/ianb_a_1637883_f0002_c.jpg)
Figure 3. Live/dead assay method to investigate cell compatibility and survival of the fibroblast cell line treated with prepared nanocomposite (scale bar = 50 µm) (A) Fluorescence microscopic images (B) MTT assay showing cell viability.
![Figure 3. Live/dead assay method to investigate cell compatibility and survival of the fibroblast cell line treated with prepared nanocomposite (scale bar = 50 µm) (A) Fluorescence microscopic images (B) MTT assay showing cell viability.](/cms/asset/25c9bb6c-c052-4a07-b8e7-d04dcc117667/ianb_a_1637883_f0003_c.jpg)
Figure 4. (a) Postoperative lateral radiograph image, (b) lateral radiograph image after one year and (c) lateral radiograph image after 2 years.
![Figure 4. (a) Postoperative lateral radiograph image, (b) lateral radiograph image after one year and (c) lateral radiograph image after 2 years.](/cms/asset/20fb22bb-a9d2-4429-ba49-d137eac1c627/ianb_a_1637883_f0004_c.jpg)
Table 1. Patient demographic details.
Table 2. Clinical and radiographic outcomes.